Helga L. R.
- Country
- Austria
- Department
- 3702; Oncology
Research Overview
- Efficacy and Safety of Sarilumab Dose Levels with a 52‑Week Prednisone Taper in Adults with Early Polymyalgia Rheumatica: Randomized Double‑Blind Placebo‑Controlled Trial
- Evaluation of Proactive Therapeutic Drug Monitoring Versus Standard Care in Sustaining Disease Control in Rheumatoid Arthritis Patients on Subcutaneous Adalimumab
- Evaluation of Methotrexate Efficacy in Achieving Clinical Disease Activity Index Remission in Patients with Active Rheumatoid Arthritis
Data & Insights
Has run more than one trial at 29 of 152 partner sites.
Specializations
Rheumatoid Arthritis Management
The investigator specializes in advanced therapeutic approaches for rheumatoid arthritis, with particular focus on monitoring and maintaining sustained disease control.
- Therapeutic Drug Monitoring (TDM)
- TNF Inhibitor Therapy
- Disease Activity Assessment
Their research encompasses innovative approaches to disease remission and clinical activity monitoring in rheumatoid arthritis patients.
Inflammatory Myopathies
The investigator conducts research in various forms of idiopathic inflammatory myopathies, focusing on novel therapeutic interventions.
- Polymyositis Treatment
- Dermatomyositis Management
- Antisynthetase Syndrome
- Overlap Myositis
Their work includes evaluation of advanced immunological treatments for inflammatory muscle conditions.
Immunotherapy Innovation
The investigator explores cutting-edge immunological treatments across various autoimmune conditions.
- IVIG Therapy Optimization
- Novel Biological Agents
- Immune-Mediating Therapies
Their research focuses on developing and evaluating new therapeutic approaches for complex autoimmune disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.